TOKEN	PREDICTED
"	O
Acta	O
Neuropathol	O
CommunActa	O
Neuropathol	O
CommunActa	O
Neuropathologica	O
Communications2051	O
-	O
5960BioMed	O
CentralLondon32404202722251793910	O
.	O
1186	O
/	O
s40478	O
-	O
020	O
-	O
00939	O
-	O
0ResearchTranscriptional	O
analyses	O
of	O
adult	O
and	O
pediatric	O
adamantinomatous	O
craniopharyngioma	O
reveals	O
similar	O
expression	O
signatures	O
regarding	O
potential	O
therapeutic	O
targetshttp	O
://	O
orcid	O
.	O
org	O
/	O
0000	O
-	O
0001	O
-	O
7359	O
-	O
6608PrinceEricEric	O
.	O
Prince	O
@	O
CUAnschutz	O
.	O
edu12WhelanRos3DonsonAndrew24StaulcupSusan1HengartnerAstrid12VijmasiTrinka12AgwuChibueze5LilleheiKevin	O
O	O
.	O
3ForemanNicholas	O
K	O
.	O
24JohnstonJames	O
M	O
.	O
6MassimiLuca78AndersonRichard	O
C	O
.	O
E	O
.	O
9SouweidaneMark	O
M	O
.	O
1011NaftelRobert	O
P	O
.	O
12LimbrickDavid	O
D	O
.	O
1314GrantGerald15NiaziToba	O
N	O
.	O
16DudleyRoy17KilburnLindsay1819JacksonEric	O
M	O
.	O
20JalloGeorge	O
I	O
.	O
21GinnKevin22SmithAmy23ChernJoshua	O
J	O
.	O
2425LeeAmy2627DrapeauAnnie28KriegerMark	O
D	O
.	O
29HandlerMichael	O
H	O
.	O
1HankinsonTodd	O
C	O
.	O
12on	O
behalf	O
of	O
the	O
Advancing	O
Treatment	O
for	O
Pediatric	O
Craniopharyngioma	O
Consortium1grid	O
.	O
413957	O
.	O
d0000	O
0001	O
0690	O
7621Division	O
of	O
Pediatric	O
Neurosurgery	O
,	O
Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
Hospital	O
Colorado	O
,	O
Aurora	O
,	O
USA	O
2Morgan	O
Adams	O
Foundation	O
Pediatric	O
Brain	O
Tumor	O
Research	O
Program	O
,	O
Aurora	O
,	O
USA	O
3grid	O
.	O
430503	O
.	O
10000	O
0001	O
0703	O
675XDepartment	O
of	O
Neurosurgery	O
,	O
University	O
of	O
Colorado	O
School	O
of	O
Medicine	O
,	O
Aurora	O
,	O
USA	O
4grid	O
.	O
413957	O
.	O
d0000	O
0001	O
0690	O
7621Division	O
of	O
Pediatric	O
Neurooncology	O
,	O
Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
Hospital	O
Colorado	O
,	O
Aurora	O
,	O
USA	O
5grid	O
.	O
4367	O
.	O
60000	O
0001	O
2355	O
7002Washington	O
University	O
in	O
St	O
.	O
Louis	O
,	O
St	O
.	O
Louis	O
,	O
USA	O
6grid	O
.	O
265892	O
.	O
20000000106344187Division	O
of	O
Pediatric	O
Neurosurgery	O
,	O
Department	O
of	O
Neurosurgery	O
,	O
University	O
of	O
Alabama	O
at	O
Birmhingham	O
,	O
Birmingham	O
,	O
USA	O
7grid	O
.	O
414603	O
.	O
4Neurochirurgia	O
Pediatrica	O
,	O
Fondazione	O
Policlinico	O
Universitario	O
A	O
.	O
Gemelli	O
IRCCS	O
,	O
Roma	O
,	O
Italy	O
8grid	O
.	O
8142	O
.	O
f0000	O
0001	O
0941	O
3192Istituto	O
di	O
Neurochirurgia	O
,	O
Universit	O
<	O
U	O
+	O
00E0	O
>	O
Cattolica	O
del	O
Sacro	O
Cuore	O
,	O
Roma	O
,	O
Italy	O
9grid	O
.	O
21729	O
.	O
3f0000000419368729Department	O
of	O
Neurosurgery	O
,	O
Columbia	O
University	O
,	O
Morgan	O
Stanley	O
Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
Hospital	O
of	O
NewYork	O
-	O
Presbyterian	O
,	O
New	O
York	O
,	O
USA	O
10grid	O
.	O
51462	O
.	O
340000	O
0001	O
2171	O
9952Department	O
of	O
Neurosurgery	O
,	O
Memorial	O
Sloan	O
Kettering	O
Cancer	O
Center	O
,	O
New	O
York	O
,	O
USA	O
11grid	O
.	O
5386	O
.	O
8000000041936877XDepartment	O
of	O
Neurological	O
Surgery	O
,	O
Weill	O
Cornell	O
Medical	O
College	O
,	O
New	O
York	O
,	O
USA	O
12grid	O
.	O
416074	O
.	O
00000	O
0004	O
0433	O
6783Department	O
of	O
Neurological	O
Surgery	O
,	O
Vanderbilt	O
University	O
Medical	O
Center	O
,	O
Monroe	O
Carell	O
Jr	O
.	O
Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
Hospital	O
at	O
Vanderbilt	O
,	O
Nashville	O
,	O
USA	O
13grid	O
.	O
4367	O
.	O
60000	O
0001	O
2355	O
7002Department	O
of	O
Pediatrics	O
,	O
Washington	O
University	O
School	O
of	O
Medicine	O
,	O
St	O
.	O
Louis	O
,	O
USA	O
14grid	O
.	O
4367	O
.	O
60000	O
0001	O
2355	O
7002Department	O
of	O
Neurosurgery	O
,	O
Washington	O
University	O
School	O
of	O
Medicine	O
,	O
St	O
.	O
Louis	O
,	O
USA	O
15grid	O
.	O
414123	O
.	O
10000	O
0004	O
0450	O
875XDepartment	O
of	O
Pediatric	O
Neurosurgery	O
,	O
Lucile	O
Packard	O
Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
Hospital	O
at	O
Stanford	O
University	O
,	O
Palo	O
Alto	O
,	O
USA	O
16grid	O
.	O
415486	O
.	O
a0000	O
0000	O
9682	O
6720Department	O
of	O
Pediatric	O
Neurosurgery	O
,	O
Nicklaus	O
Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
Hospital	O
,	O
Miami	O
,	O
USA	O
17grid	O
.	O
14709	O
.	O
3b0000	O
0004	O
1936	O
8649Department	O
of	O
Neurosurgery	O
,	O
McGill	O
University	O
,	O
Montreal	O
,	O
Canada	O
18grid	O
.	O
239560	O
.	O
b0000	O
0004	O
0482	O
1586Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
National	O
Health	O
System	O
,	O
Center	O
for	O
Cancer	O
and	O
Blood	O
Disorders	O
,	O
Washington	O
,	O
DC	O
USA	O
19grid	O
.	O
239560	O
.	O
b0000	O
0004	O
0482	O
1586Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
National	O
Health	O
System	O
,	O
Brain	O
Tumor	O
Institute	O
,	O
Washington	O
,	O
DC	O
USA	O
20grid	O
.	O
21107	O
.	O
350000	O
0001	O
2171	O
9311Department	O
of	O
Neurosurgery	O
,	O
Johns	O
Hopkins	O
University	O
School	O
of	O
Medicine	O
,	O
Baltimore	O
,	O
USA	O
21grid	O
.	O
413611	O
.	O
00000	O
0004	O
0467	O
2330Johns	O
Hopkins	O
All	O
Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
Hospital	O
,	O
Institute	O
of	O
Brain	O
Protection	O
Sciences	O
,	O
St	O
Petersburg	O
,	O
USA	O
22grid	O
.	O
239559	O
.	O
10000	O
0004	O
0415	O
5050The	O
Division	O
of	O
Pediatric	O
Hematology	O
and	O
Oncology	O
,	O
the	O
Department	O
of	O
Pediatrics	O
,	O
Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
Mercy	O
Hospital	O
,	O
Kansas	O
City	O
,	O
USA	O
23grid	O
.	O
413939	O
.	O
50000	O
0004	O
0456	O
3548Department	O
of	O
Pediatric	O
Hematology	O
-	O
Oncology	O
,	O
Arnold	O
Palmer	O
Hospital	O
,	O
Orlando	O
,	O
USA	O
24grid	O
.	O
189967	O
.	O
80000	O
0001	O
0941	O
6502Departments	O
of	O
Pediatrics	O
and	O
Neurosurgery	O
,	O
Emory	O
University	O
School	O
of	O
Medicine	O
,	O
Atlanta	O
,	O
USA	O
25grid	O
.	O
428158	O
.	O
20000	O
0004	O
0371	O
6071Department	O
of	O
Pediatric	O
Neurosurgery	O
,	O
Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
Healthcare	O
of	O
Atlanta	O
,	O
Atlanta	O
,	O
USA	O
26grid	O
.	O
240741	O
.	O
40000	O
0000	O
9026	O
4165Department	O
of	O
Pediatric	O
Neurosurgery	O
,	O
Seattle	O
Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
Hospital	O
,	O
Seattle	O
,	O
USA	O
27grid	O
.	O
34477	O
.	O
330000000122986657Department	O
of	O
Neurological	O
Surgery	O
,	O
University	O
of	O
Washington	O
School	O
of	O
Medicine	O
,	O
Seattle	O
,	O
USA	O
28grid	O
.	O
240344	O
.	O
50000	O
0004	O
0392	O
3476Division	O
of	O
Pediatric	O
Neurosurgery	O
,	O
Nationwide	O
Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
Hospital	O
,	O
Columbus	O
,	O
USA	O
29grid	O
.	O
239546	O
.	O
f0000	O
0001	O
2153	O
6013Department	O
of	O
Neurosurgery	O
,	O
Children	O
<	O
U	O
+	O
2019	O
>	O
s	O
Hospital	O
Los	O
Angeles	O
,	O
Los	O
Angeles	O
,	O
USA	O
13520201352020202086827120202742020	O
<	O
U	O
+	O
00A9	O
>	O
The	O
Author	O
(	O
s	O
)	O
2020Open	O
AccessThis	O
article	O
is	O
licensed	O
under	O
a	O
Creative	O
Commons	O
Attribution	O
4	O
.	O
0	O
International	O
License	O
,	O
which	O
permits	O
use	O
,	O
sharing	O
,	O
adaptation	O
,	O
distribution	O
and	O
reproduction	O
in	O
any	O
medium	O
or	O
format	O
,	O
as	O
long	O
as	O
you	O
give	O
appropriate	O
credit	O
to	O
the	O
original	O
author	O
(	O
s	O
)	O
and	O
the	O
source	O
,	O
provide	O
a	O
link	O
to	O
the	O
Creative	O
Commons	O
licence	O
,	O
and	O
indicate	O
if	O
changes	O
were	O
made	O
.	O

The	O
images	O
or	O
other	O
third	O
party	O
material	O
in	O
this	O
article	O
are	O
included	O
in	O
the	O
article	O
'	O
s	O
Creative	O
Commons	O
licence	O
,	O
unless	O
indicated	O
otherwise	O
in	O
a	O
credit	O
line	O
to	O
the	O
material	O
.	O

If	O
material	O
is	O
not	O
included	O
in	O
the	O
article	O
'	O
s	O
Creative	O
Commons	O
licence	O
and	O
your	O
intended	O
use	O
is	O
not	O
permitted	O
by	O
statutory	O
regulation	O
or	O
exceeds	O
the	O
permitted	O
use	O
,	O
you	O
will	O
need	O
to	O
obtain	O
permission	O
directly	O
from	O
the	O
copyright	O
holder	O
.	O

To	O
view	O
a	O
copy	O
of	O
this	O
licence	O
,	O
visit	O
http	O
://	O
creativecommons	O
.	O
org	O
/	O
licenses	O
/	O
by	O
/	O
4	O
.	O
0	O
/.	O

The	O
Creative	O
Commons	O
Public	O
Domain	O
Dedication	O
waiver	O
(	O
http	O
://	O
creativecommons	O
.	O
org	O
/	O
publicdomain	O
/	O
zero	O
/	O
1	O
.	O
0	O
/)	O
applies	O
to	O
the	O
data	O
made	O
available	O
in	O
this	O
article	O
,	O
unless	O
otherwise	O
stated	O
in	O
a	O
credit	O
line	O
to	O
the	O
data	O
.	O

Adamantinomatous	O
craniopharyngioma	O
(	O
ACP	O
)	O
is	O
a	O
biologically	O
benign	O
but	O
clinically	O
aggressive	O
lesion	O
that	O
has	O
a	O
significant	O
impact	O
on	O
quality	O
of	O
life	O
.	O

The	O
incidence	O
of	O
the	O
disease	O
has	O
a	O
bimodal	O
distribution	O
,	O
with	O
peaks	O
occurring	O
in	O
children	O
and	O
older	O
adults	O
.	O

Our	O
group	O
previously	O
published	O
the	O
results	O
of	O
a	O
transcriptome	O
analysis	O
of	O
pediatric	O
ACPs	O
that	O
identified	O
several	O
genes	O
that	O
were	O
consistently	O
overexpressed	O
relative	O
to	O
other	O
pediatric	O
brain	O
tumors	O
and	O
normal	O
tissue	O
.	O

We	O
now	O
present	O
the	O
results	O
of	O
a	O
transcriptome	O
analysis	O
comparing	O
pediatric	O
to	O
adult	O
ACP	O
to	O
identify	O
biological	O
differences	O
between	O
these	O
groups	O
that	O
may	O
provide	O
novel	O
therapeutic	O
insights	O
or	O
support	O
the	O
assertion	O
that	O
potential	O
therapies	O
identified	O
through	O
the	O
study	O
of	O
pediatric	O
ACP	O
may	O
also	O
have	O
a	O
role	O
in	O
adult	O
ACP	O
.	O

Using	O
our	O
compiled	O
transcriptome	O
dataset	O
of	O
27	O
pediatric	O
and	O
9	O
adult	O
ACPs	O
,	O
obtained	O
through	O
the	O
Advancing	O
Treatment	O
for	O
Pediatric	O
Craniopharyngioma	O
Consortium	O
,	O
we	O
interrogated	O
potential	O
age	O
-	O
related	O
transcriptional	O
differences	O
using	O
several	O
rigorous	O
mathematical	O
analyses	O
.	O

These	O
included	O
:	O
canonical	O
differential	O
expression	O
analysis	O
;	O
divisive	O
,	O
agglomerative	O
,	O
and	O
probabilistic	O
based	O
hierarchical	O
clustering	O
;	O
information	O
theory	O
based	O
characterizations	O
;	O
and	O
the	O
deep	O
learning	O
approach	O
,	O
HD	O
Spot	O
.	O

Our	O
work	O
indicates	O
that	O
there	O
is	O
no	O
therapeutically	O
relevant	O
difference	O
in	O
ACP	O
gene	O
expression	O
based	O
on	O
age	O
.	O

As	O
such	O
,	O
potential	O
therapeutic	O
targets	O
identified	O
in	O
pediatric	O
ACP	O
are	O
also	O
likely	O
to	O
have	O
relvance	O
for	O
adult	O
patients	O
.	O

Introduction	O
Adamantinomatous	O
craniopharyngioma	O
(	O
ACP	O
)	O
is	O
a	O
histologically	O
benign	O
brain	O
tumor	O
that	O
arises	O
in	O
the	O
sellar	O
/	O
suprasellar	O
region	O
.	O

Despite	O
being	O
a	O
WHO	O
grade	O
I	O
lesion	O
,	O
ACP	O
often	O
follows	O
a	O
clinically	O
aggressive	O
course	O
and	O
has	O
been	O
associated	O
with	O
the	O
worst	O
quality	O
of	O
life	O
outcomes	O
of	O
any	O
pediatric	O
brain	O
tumor	O
[	O
1	O
].	O

Unlike	B
its	O
histological	O
counterpart	O
,	O
Papillary	O
Craniopharyngioma	O
(	O
PCP	O
),	O
ACP	O
is	O
characterized	O
by	O
bimodal	O
incidence	O
,	O
with	O
spikes	O
during	O
childhood	O
and	O
adulthood	O
[	O
2	O
,	O
3	O
].	O

Also	O
unlike	B
PCP	O
,	O
for	O
which	O
promising	O
therapies	O
targeting	O
the	O
BRAFv600e	O
mutation	O
are	O
in	O
clinical	O
trials	O
,	O
ACP	O
is	O
known	O
to	O
harbor	O
only	O
a	O
mutation	O
in	O
the	O
CTNNB1	O
gene	O
,	O
leading	O
to	O
a	O
failure	O
of	O
normal	O
<	O
U	O
+	O
03B2	O
>-	O
Catenin	O
degradation	O
,	O
with	O
resultant	O
cytoplasmic	O
and	O
nuclear	O
accumulation	O
in	O
a	O
subset	O
of	O
cells	O
,	O
where	O
it	O
can	O
act	O
as	O
a	O
transcription	O
factor	O
that	O
may	O
promote	O
ACP	O
pathogenesis	O
.	O

Unfortunately	O
,	O
this	O
understanding	O
has	O
not	O
yet	O
led	O
to	O
the	O
introduction	O
of	O
effective	O
targeted	O
therapies	O
against	O
ACP	O
.	O

As	O
such	O
,	O
current	O
therapies	O
consist	O
primarily	O
of	O
surgery	O
,	O
radiation	O
and	O
intracystic	O
treatments	O
.	O

While	B
downstream	O
effects	O
of	O
the	O
CTNNB1	O
mutation	O
appear	O
to	O
be	O
the	O
most	O
likely	O
driver	O
mutation	O
in	O
ACP	O
,	O
it	O
is	O
likely	O
that	O
tumorigenesis	O
is	O
multifactorial	O
.	O

Recent	O
studies	O
of	O
the	O
human	O
ACP	O
transcriptome	O
,	O
using	O
both	O
microarray	O
[	O
4	O
]	O
and	O
RNA	O
sequencing	O
[	O
5	O
],	O
have	O
identified	O
potential	O
novel	O
therapeutic	O
targets	O
.	O

However	B
,	O
this	O
work	O
has	O
focused	O
exclusively	O
on	O
pediatric	O
tumors	O
,	O
leaving	O
open	O
the	O
question	O
of	O
whether	B
these	O
potential	O
therapies	O
could	O
be	O
relevant	O
in	O
adult	O
patients	O
,	O
who	O
represent	O
approximately	O
69	O
%	O
of	O
all	O
patients	O
with	O
ACP	O
[	O
2	O
,	O
3	O
].	O
This	O
work	O
sought	O
to	O
investigate	O
,	O
using	O
bulk	O
RNA	O
sequencing	O
of	O
adult	O
and	O
pediatric	O
ACP	O
,	O
whether	B
there	O
is	O
evidence	O
that	O
patients	O
with	O
ACP	O
from	O
different	B
age	O
cohorts	O
could	O
be	O
expected	O
to	O
respond	O
to	O
the	O
same	O
targeted	O
therapeutic	O
strategies	O
.	O

In	O
order	O
to	O
identify	O
even	O
subtle	O
differences	O
in	O
the	O
transcriptome	O
profile	O
of	O
the	O
2	O
tissue	O
populations	O
,	O
we	O
conducted	O
a	O
highly	O
rigorous	O
mathematical	O
analysis	O
that	O
considered	O
the	O
potential	O
for	O
both	O
linear	O
and	O
non	O
-	O
linear	O
age	O
group	O
-	O
related	O
dependencies	O
within	O
the	O
data	O
.	O

Materials	O
and	O
methods	O
Tumor	O
samples	O
A	O
total	O
of	O
36	O
craniopharyngioma	O
tumor	O
samples	O
,	O
as	O
diagnosed	O
by	O
surgical	O
pathology	O
,	O
were	O
included	O
in	O
this	O
study	O
(	O
Table	O
S1	O
).	O

Twenty	O
-	O
seven	O
were	O
acquired	O
during	O
surgery	O
for	O
pediatric	O
patients	O
(	O
age	O
at	O
surgery	O
<<	O
U	O
+	O
2009	O
>	O
18	O
<	O
U	O
+	O
2009	O
>	O
years	O
;	O
mean	O
<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
8	O
.	O
4	O
<	O
U	O
+	O
2009	O
>	O
years	O
,	O
median	O
<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
8	O
.	O
0	O
<	O
U	O
+	O
2009	O
>	O
years	O
),	O
and	O
9	O
from	O
adults	O
(	O
age	O
at	O
surgery	O
<	O
U	O
+	O
2265	O
>	O
18	O
<	O
U	O
+	O
2009	O
>	O
years	O
;	O
mean	O
<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
47	O
.	O
9	O
<	O
U	O
+	O
2009	O
>	O
years	O
,	O
median	O
<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
44	O
.	O
0	O
<	O
U	O
+	O
2009	O
>	O
years	O
).	O

The	O
pediatric	O
specimens	O
were	O
obtained	O
from	O
patients	O
who	O
underwent	O
surgery	O
at	O
member	O
institutions	O
of	O
the	O
Advancing	O
Treatment	O
for	O
Pediatric	O
Craniopharyngioma	O
(	O
ATPC	O
)	O
consortium	O
.	O

Adult	O
specimens	O
were	O
obtained	O
from	O
University	O
of	O
Colorado	O
Hospital	O
and	O
from	O
the	O
University	O
of	O
Alabama	O
,	O
Birmingham	O
.	O

Tumor	O
samples	O
were	O
snap	O
-	O
frozen	O
in	O
liquid	O
nitrogen	O
in	O
the	O
operating	O
room	O
and	O
subsequently	O
stored	O
in	O
freezers	O
at	O
<	O
U	O
+	O
2212	O
><	O
U	O
+	O
2009	O
>	O
80	O
<	O
U	O
+	O
2009	O
><	O
U	O
+	O
00B0	O
>	O
C	O
.	O

For	O
transport	O
between	O
institutions	O
,	O
samples	O
were	O
packaged	O
on	O
dry	O
ice	O
,	O
shipped	O
via	O
overnight	O
courier	O
,	O
and	O
immediately	O
placed	O
in	O
a	O
freezer	O
at	O
<	O
U	O
+	O
2212	O
><	O
U	O
+	O
2009	O
>	O
80	O
<	O
U	O
+	O
2009	O
><	O
U	O
+	O
00B0	O
>	O
C	O
.	O

RNA	O
extraction	O
and	O
sequencing	O
RNA	O
was	O
extracted	O
from	O
snap	O
-	O
frozen	O
samples	O
using	O
the	O
Allprep	O
DNA	O
/	O
RNA	O
Kit	O
(	O
QIAGEN	O
<	O
U	O
+	O
00AE	O
>,	O
Maryland	O
,	O
USA	O
).	O

The	O
quality	O
of	O
the	O
isolated	O
mRNA	O
was	O
determined	O
via	O
DNA	O
analysis	O
ScreenTape	O
(	O
Aligent	O
Technologies	O
).	O

Samples	O
that	O
passed	O
quality	O
control	O
were	O
used	O
to	O
generate	O
cDNA	O
libraries	O
using	O
the	O
Illumina	O
TruSeq	O
Stranded	O
mRNA	O
Sample	O
Prep	O
Kit	O
.	O

RNA	O
sequencing	O
was	O
carried	O
out	O
using	O
the	O
Illumina	O
HiSeq4000	O
platform	O
with	O
paired	O
-	O
end	O
reads	O
(	O
2	O
<	O
U	O
+	O
2009	O
><	O
U	O
+	O
00D7	O
><	O
U	O
+	O
2009	O
>	O
151	O
).	O

On	O
average	O
,	O
40	O
million	O
reads	O
were	O
collected	O
for	O
each	O
sample	O
and	O
outputted	O
to	O
FASTQ	O
files	O
.	O

Sequencing	O
reads	O
were	O
subjected	O
to	O
adapter	O
-	O
trimming	O
and	O
quality	O
control	O
using	O
the	O
Trimmomatic	O
package	O
[	O
6	O
].	O

Files	O
were	O
mapped	O
to	O
the	O
GRCh38	O
genome	O
(	O
v33	O
)	O
and	O
subsequently	O
sorted	O
to	O
yield	O
BAM	O
files	O
using	O
the	O
standard	O
STAR	O
pipeline	O
[	O
7	O
].	O

BAM	O
files	O
were	O
converted	O
to	O
feature	O
counts	O
using	O
the	O
R	O
Bioconductor	O
package	O
RSubread	O
[	O
8	O
].	O

Normal	O
pituitary	O
RNA	O
sequencing	O
data	O
was	O
obtained	O
from	O
the	O
GTEx	O
portal	O
(	O
www	O
.	O
gtexportal	O
.	O
org	O
).	O

Analysis	O
methodology	O
Due	O
to	O
the	O
possibility	O
that	O
adult	O
and	O
pediatric	O
transcription	O
patterns	O
would	O
be	O
distinguished	O
by	O
only	O
subtle	O
expression	O
differences	O
,	O
we	O
chose	O
a	O
multimodal	O
bioinformatic	O
approach	O
.	O

This	O
was	O
designed	O
to	O
assess	O
for	O
both	O
linear	O
and	O
non	O
-	O
linear	O
relationships	O
,	O
but	O
also	O
to	O
insulate	O
the	O
statistical	O
analysis	O
from	O
potentially	O
false	O
assumptions	O
.	O

Canonical	O
differential	O
expression	O
analysis	O
Feature	O
counts	O
for	O
transcriptomes	O
of	O
adult	O
and	O
pediatric	O
ACP	O
samples	O
were	O
analytically	O
processed	O
using	O
a	O
standard	O
DESeq2	O
protocol	O
[	O
9	O
].	O

As	O
the	O
experiment	O
intended	O
to	O
rule	O
out	O
differences	O
in	O
gene	O
expression	O
between	O
the	O
2	O
age	O
groups	O
,	O
an	O
Independent	O
Hypothesis	O
Weighted	O
(	O
IHW	O
)	O
p	O
-	O
value	O
threshold	O
of	O
0	O
.	O
1	O
was	O
utilized	O
to	O
filter	O
transcripts	O
identified	O
as	O
differentially	O
expressed	O
.	O

Results	O
were	O
visualized	O
using	O
a	O
Mass	O
Action	O
(	O
MA	O
)	O
plot	O
and	O
a	O
Euclidean	O
Distance	O
Matrix	O
was	O
employed	O
to	O
serve	O
as	O
a	O
qualitative	O
foundation	O
from	O
which	O
to	O
make	O
statistical	O
methodology	O
arguments	O
downstream	O
.	O
Divisive	O
,	O
agglomerative	O
,	O
and	O
probabilistic	O
clustering	O
was	O
performed	O
using	O
the	O
DIANA	O
,	O
AGNES	O
,	O
and	O
FANNY	O
functions	O
in	O
the	O
cluster	O
R	O
package	O
[	O
10	O
],	O
respectively	O
.	O

AGNES	O
was	O
implemented	O
with	O
the	O
complete	O
-	O
linkage	O
method	O
.	O

Complete	O
-	O
linkage	O
clustering	O
groups	O
variables	O
by	O
their	O
most	O
dissimilar	O
members	O
and	O
also	O
avoids	O
combining	O
clusters	O
with	O
highly	O
similar	O
elements	O
(	O
as	O
opposed	I
to	I
single	O
-	O
linkage	O
).	O

As	O
shown	O
below	O
in	O
Fig	O
.<	O
U	O
+	O
00A0	O
>	O
1b	O
,	O
we	O
expect	O
no	O
linear	O
dissimilarity	O
between	O
transcriptomes	O
relative	O
to	O
age	O
group	O
,	O
making	O
complete	O
-	O
linkage	O
an	O
appropriate	O
clustering	O
strategy	O
.	O

As	O
subtle	O
differences	O
in	O
the	O
gene	O
expression	O
patterns	O
could	O
be	O
expected	O
,	O
complete	O
-	O
linkage	O
was	O
employed	O
due	O
to	O
its	O
superiority	O
over	O
a	O
single	O
-	O
linkage	O
approach	O
in	O
handling	O
data	O
groups	O
that	O
closely	O
neighbor	O
one	O
another	O
.	O

DIANA	O
and	O
AGNES	O
calculate	O
metrics	O
for	O
cluster	O
organization	O
known	O
as	O
the	O
Divisive	O
Coefficient	O
(	O
DC	O
)	O
and	O
Agglomerative	O
Coefficient	O
(	O
AC	O
),	O
respectively	O
.	O

These	O
coefficients	O
range	O
between	O
0	O
and	O
1	O
,	O
and	O
indicate	O
the	O
precision	O
with	O
which	O
the	O
dendrogram	O
describes	O
the	O
data	O
,	O
with	O
1	O
being	O
the	O
most	O
ideal	O
structure	O
and	O
0	O
being	O
the	O
worst	O
.	O

As	O
FANNY	O
is	O
not	O
a	O
hierarchical	O
algorithm	O
,	O
and	O
is	O
visualized	O
in	O
principal	O
component	O
space	O
,	O
the	O
percent	O
of	O
variance	O
explained	O
serves	O
as	O
a	O
surrogate	O
value	O
for	O
AC	O
and	O
DC	O
(	O
i	O
.	O
e	O
.,	O
a	O
larger	O
percent	O
variance	O
explained	O
value	O
indicates	O
how	O
well	O
a	O
datasets	O
information	O
is	O
represented	O
in	O
the	O
decomposed	O
space	O
).	O

Fig	O
.	O

1	O
Global	O
Transcriptional	O
Profiling	O
of	O
Adult	O
and	O
Pediatric	O
ACP	O
Samples	O
.	O

a	O
MA	O
-	O
plot	O
visualizing	O
transcripts	O
indicating	O
significant	O
(	O
Independent	O
Hypothesis	O
Weighting	O
(	O
IHW	O
)	O
adjusted	O
p	O
-	O
value	O
<<	O
U	O
+	O
2009	O
>	O
0	O
.	O
1	O
;	O
red	O
)	O
and	O
insignificant	O
genes	O
(	O
black	O
)	O
as	O
determined	O
in	O
differential	O
expression	O
analysis	O
;	O
transcripts	O
enriched	O
relative	O
to	O
pediatric	O
patients	O
are	O
log	O
fold	O
change	O
(	O
LFC	O
)	O
up	O
(><	O
U	O
+	O
2009	O
>	O
0	O
)	O
and	O
transcripts	O
enriched	O
relative	O
to	O
adult	O
patients	O
are	O
LFC	O
down	O
(<<	O
U	O
+	O
2009	O
>	O
0	O
).	O

b	O
Euclidean	O
sample	O
distance	O
matrix	O
without	O
clustering	O
demonstrated	O
the	O
relative	O
heterogeneity	O
across	O
all	O
sample	O
groups	O
from	O
a	O
global	O
transcriptional	O
expression	O
perspective	O
.	O

c	O
-	O
e	O
Clustering	O
paradigms	O
utilized	O
in	O
dataset	O
exploration	O
.	O

c	O
Dendrogram	O
yielded	O
from	O
the	O
DIvisive	O
ANAlysis	O
(	O
DIANA	O
)	O
hierarchical	O
clustering	O
algorithm	O
.	O

d	O
Dendrogram	O
produced	O
by	O
the	O
AGlomerative	O
NESting	O
(	O
AGNES	O
)	O
hierarchical	O
clustering	O
algorithm	O
using	O
complete	O
linkage	O
.	O

e	O
Clustering	O
partitions	O
and	O
group	O
ellipsoids	O
generated	O
by	O
the	O
fuzzy	O
analysis	O
(	O
FANNY	O
)	O
probabilistic	O
k	O
-	O
centroid	O
technique	O
.	O

f	O
-	O
h	O
Silhouette	O
plots	O
depicting	O
mean	O
silhouette	O
width	O
across	O
a	O
range	O
of	O
numbers	O
of	O
clusters	O
.	O

Possible	O
silhouette	O
values	O
are	O
within	O
[<	O
U	O
+	O
2212	O
><	O
U	O
+	O
2009	O
>	O
1	O
,	O
1	O
]	O
where	O
a	O
value	O
of	O
1	O
indicates	O
the	O
cluster	O
member	O
is	O
most	O
-	O
closely	O
related	O
to	O
the	O
members	O
within	O
that	O
cluster	O
and	O
dissimilar	O
to	O
those	O
outside	O
of	O
the	O
cluster	O
.	O

As	O
values	O
approach	O
<	O
U	O
+	O
2212	O
><	O
U	O
+	O
2009	O
>	O
1	O
,	O
the	O
opposite	B
is	O
true	O
which	O
indicates	O
the	O
cluster	O
member	O
is	O
an	O
outlier	O
within	O
the	O
cluster	O
.	O

f	O
Silhouette	O
plot	O
generated	O
from	O
the	O
DIANA	O
clustering	O
presented	O
in	O
1c	O
.	O

g	O
Silhouette	O
plot	O
produced	O
by	O
the	O
AGNES	O
algorithm	O
output	O
presented	O
in	O
1d	O
.	O

h	O
Silhouette	O
plot	O
yielded	O
by	O
the	O
FANNY	O
algorithm	O
results	O
visualized	O
in	O
1e	O
.	O

Although	O
cluster	O
analysis	O
is	O
a	O
primarily	O
descriptive	O
mathematical	O
technique	O
,	O
we	O
calculated	O
the	O
silhouette	O
width	O
as	O
a	O
means	O
to	O
make	O
a	O
quantitative	O
comparison	O
of	O
the	O
differential	O
expression	O
data	O
.	O

Silhouette	O
widths	O
range	O
between	O
<	O
U	O
+	O
2212	O
><	O
U	O
+	O
2009	O
>	O
1	O
and	O
1	O
.	O

A	O
value	O
of	O
1	O
indicates	O
that	O
the	O
cluster	O
members	O
are	O
closely	O
related	O
to	O
the	O
other	O
members	O
of	O
the	O
cluster	O
,	O
and	O
not	O
to	O
members	O
outside	O
the	O
cluster	O
.	O

A	O
value	O
of	O
<	O
U	O
+	O
2212	O
><	O
U	O
+	O
2009	O
>	O
1	O
suggests	O
the	O
cluster	O
member	O
is	O
an	O
outlier	O
within	O
the	O
cluster	O
and	O
is	O
actually	O
more	O
representative	O
of	O
other	O
clusters	O
.	O

The	O
mean	O
Silhouette	O
Value	O
was	O
calculated	O
for	O
a	O
range	O
of	O
cluster	O
numbers	O
for	O
the	O
DIANA	O
,	O
AGNES	O
,	O
and	O
FANNY	O
algorithms	O
(	O
Fig	O
.	O

1f	O
,	O
g	O
,	O
h	O
,	O
respectively	O
).	O

Information	O
theory	O
analysis	O
In	O
order	O
to	O
extend	O
the	O
analysis	O
beyond	O
the	O
linear	O
methodology	O
utilized	O
in	O
the	O
canonical	O
analysis	O
,	O
we	O
calculated	O
the	O
Kullback	O
-	O
Leibler	O
(	O
KL	O
)	O
divergence	O
(	O
DKL	O
)	O
and	O
Maximal	O
Information	O
Coefficient	O
(	O
MIC	O
).	O

This	O
was	O
necessary	O
because	O
non	O
-	O
linear	O
transcriptional	O
relationships	O
(	O
i	O
.	O
e	O
.,	O
dynamic	O
networks	O
of	O
transcripts	O
)	O
between	O
age	O
groups	O
could	O
exist	O
and	O
are	O
likely	O
abundant	O
,	O
as	O
seen	O
by	O
the	O
development	O
of	O
numerous	O
pathway	O
-	O
based	O
analytical	O
tools	O
(	O
e	O
.	O
g	O
.,	O
GSEA	O
,	O
GO	O
-	O
terms	O
,	O
Reactome	O
,	O
etc	O
.).	O

While	B
these	O
types	O
of	O
modules	O
are	O
interesting	O
they	O
often	O
require	O
predefined	O
lists	O
.	O

However	B
,	O
utilizing	O
information	O
theory	O
allows	O
us	O
to	O
inspect	O
potential	O
networks	O
in	O
the	O
absence	O
of	O
prior	O
known	O
networks	O
,	O
and	O
also	O
reduces	O
analytical	O
bias	O
.	O
DKL	O
is	O
a	O
mathematical	O
approach	O
to	O
identify	O
differences	O
between	O
data	O
distributions	O
through	O
non	O
-	O
linear	O
integration	O
.	O

While	B
this	O
is	O
most	O
commonly	O
used	O
to	O
compare	O
machine	O
learning	O
outputs	O
to	O
ground	O
truth	O
distributions	O
,	O
we	O
employed	O
it	O
by	O
treating	O
one	O
distribution	O
(	O
e	O
.	O
g	O
.,	O
pediatric	O
)	O
as	O
the	O
predicted	O
distribution	O
and	O
the	O
other	O
distribution	O
(	O
e	O
.	O
g	O
.,	O
adult	O
)	O
as	O
the	O
target	O
distribution	O
(	O
e	O
.	O
g	O
.	O

<	O
U	O
+	O
201C	O
>	O
ground	O
truth	O
<	O
U	O
+	O
201D	O
>).	O

This	O
scenario	O
effectively	O
asks	O
the	O
following	O
question	O
:	O
given	O
the	O
expression	O
distribution	O
of	O
the	O
adult	O
cohort	O
,	O
how	O
well	O
can	O
the	O
distribution	O
of	O
the	O
pediatric	O
cohort	O
be	O
predicted	O
.	O

To	O
calculate	O
DKL	O
,	O
raw	O
feature	O
counts	O
generated	O
by	O
RSubread	O
were	O
first	O
class	O
-	O
balanced	O
using	O
the	O
Synthetic	O
Minority	O
Oversampling	O
Technique	O
(	O
SMOTE	O
)	O
[	O
11	O
]	O
via	O
the	O
python	O
imblearn	O
package	O
[	O
12	O
].	O

DKL	O
values	O
were	O
then	O
calculated	O
for	O
the	O
synthetically	O
balanced	O
dataset	O
using	O
the	O
python	O
scipy	O
stats	O
module	O
.	O
MIC	O
is	O
used	O
to	O
measure	O
the	O
strength	O
of	O
any	O
linear	O
and	O
/	O
or	O
non	O
-	O
linear	O
relationship	O
between	O
two	O
variables	O
.	O

This	O
is	O
accomplished	O
by	O
binning	O
continuous	O
variables	O
and	O
iteratively	O
calculating	O
mutual	O
information	O
(	O
i	O
.	O
e	O
.,	O
the	O
dependence	O
between	O
variables	O
)	O
to	O
identify	O
the	O
maxima	O
.	O

By	O
plotting	O
MIC	O
against	O
Pearson	O
<	O
U	O
+	O
2019	O
>	O
s	O
R	O
the	O
magnitude	O
of	O
the	O
relationship	O
between	O
the	O
variables	O
can	O
be	O
visualized	O
(	O
MIC	O
<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
0	O
indicates	O
no	O
relationship	O
;	O
MIC	O
<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
1	O
indicates	O
highly	O
related	O
),	O
as	O
can	O
the	O
nature	O
of	O
the	O
relationship	O
(	O
linear	O
vs	O
.	O
non	O
-	O
linear	O
).	O

MIC	O
was	O
calculated	O
using	O
the	O
python	O
minepy	O
module	O
[	O
13	O
].	O

HD	O
spot	O
analysis	O
Raw	O
feature	O
counts	O
derived	O
from	O
RSubread	O
were	O
submitted	O
to	O
the	O
HD	O
Spot	O
algorithm	O
[	O
14	O
].	O

Due	O
to	O
the	O
substantial	O
imbalance	O
of	O
data	O
classes	O
,	O
the	O
HD	O
Spot	O
algorithm	O
was	O
optimized	O
with	O
respect	O
to	O
maximizing	O
the	O
area	O
under	O
the	O
precision	O
-	O
recall	O
(	O
AUPR	O
)	O
curve	O
.	O

HD	O
Spot	O
developed	O
a	O
classifier	O
that	O
achieved	O
an	O
average	O
AUPR	O
value	O
of	O
1	O
.	O
00	O
over	O
5	O
-	O
fold	O
cross	O
-	O
validation	O
and	O
subsequently	O
determined	O
the	O
mean	O
absolute	O
Shapley	O
value	O
for	O
each	O
transcript	O
.	O

Shapley	O
values	O
can	O
conceptually	O
be	O
understood	O
as	O
importance	O
scores	O
.	O

In	O
this	O
context	O
,	O
a	O
higher	O
Shapley	O
value	O
means	O
a	O
transcript	O
is	O
more	O
important	O
in	O
determining	O
the	O
age	O
group	O
from	O
which	O
the	O
sample	O
was	O
taken	O
.	O

The	O
top	O
50	O
transcripts	O
ranked	O
by	O
Shapley	O
value	O
and	O
the	O
list	O
of	O
20	O
previously	O
identified	O
therapeutic	O
targets	O
were	O
then	O
submitted	O
for	O
Metascape	O
[	O
15	O
]	O
express	O
analysis	O
to	O
explore	O
potential	O
ontologic	O
connections	O
between	O
gene	O
sets	O
using	O
GO	O
terms	O
.	O

Results	O
Canonical	O
differential	O
expression	O
analysis	O
reveals	O
no	O
therapeutically	O
relevant	O
distinction	O
between	O
adult	O
and	O
pediatric	O
ACP	O
specimens	O
Overall	O
,	O
87	O
.	O
3	O
%	O
of	O
the	O
transcripts	O
interrogated	O
were	O
insignificant	O
(	O
IHW	O
p	O
-	O
value	O
><	O
U	O
+	O
2009	O
>	O
0	O
.	O
1	O
)	O
and	O
slightly	O
more	O
transcripts	O
enriched	O
within	O
the	O
pediatric	O
population	O
versus	O
the	O
adult	O
population	O
(	O
6	O
.	O
8	O
%	O
versus	O
5	O
.	O
9	O
%,	O
respectively	O
,	O
Fig	O
.	O

1a	O
).	O

Considerable	O
heterogeneity	O
between	O
all	O
samples	O
(	O
irrespective	O
of	O
age	O
group	O
)	O
was	O
identified	O
with	O
the	O
Euclidean	O
distance	O
matrix	O
(	O
Fig	O
.	O

1b	O
).	O

Both	O
the	O
agglomerative	O
and	O
divisive	O
clustering	O
algorithms	O
demonstrated	O
reliable	O
data	O
organization	O
(	O
Fig	O
.	O

1c	O
-	O
d	O
;	O
Divisive	O
Coefficient	O
[	O
DC	O
]<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
0	O
.	O
66	O
,	O
Agglomerative	O
Coefficient	O
[	O
AC	O
]<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
0	O
.	O
59	O
)	O
as	O
well	O
as	O
the	O
absence	O
of	O
distinct	O
clusters	O
between	O
the	O
adult	O
and	O
pediatric	O
ACP	O
samples	O
.	O

Congruently	O
,	O
probabilistic	O
analysis	O
in	O
2D	O
principal	O
component	O
space	O
,	O
using	O
FANNY	O
,	O
depicted	O
nearly	O
70	O
%	O
of	O
the	O
data	O
variance	O
(	O
69	O
.	O
93	O
%,	O
Fig	O
.	O

1e	O
)	O
and	O
failed	O
to	O
partition	O
the	O
data	O
into	O
groups	O
based	O
on	O
age	O
cohort	O
.	O

Further	O
analyses	O
of	O
these	O
clustering	O
approaches	O
,	O
using	O
silhouette	O
plots	O
to	O
quantify	O
clustering	O
integrity	O
,	O
demonstrated	O
that	O
k	O
<	O
U	O
+	O
00A0	O
>=<	O
U	O
+	O
2009	O
>	O
2	O
yields	O
the	O
optimal	O
clustering	O
(	O
Fig	O
.	O

1f	O
-	O
h	O
).	O

However	O
,	O
all	O
silhouette	O
widths	O
are	O
close	O
to	O
0	O
(	O
maximum	O
<	O
U	O
+	O
2248	O
>	O
0	O
.	O
30	O
),	O
indicating	O
that	O
clusters	O
are	O
not	O
unique	O
from	O
one	O
another	O
and	O
cluster	O
memberships	O
could	O
easily	O
be	O
randomized	O
another	O
way	O
.	O

When	O
examined	O
as	O
a	O
whole	O
,	O
agglomerative	O
,	O
divisive	O
,	O
and	O
probabilistic	O
clustering	O
algorithms	O
yield	O
consistent	O
and	O
well	O
-	O
organized	O
results	O
,	O
indicating	O
that	O
the	O
transcriptomes	O
of	O
ACP	O
specimens	O
do	O
not	O
cluster	O
based	O
on	O
the	O
age	O
of	O
the	O
patient	O
from	O
which	O
they	O
were	O
obtained	O
.	O
Our	O
group	O
previously	O
identified	O
a	O
group	O
of	O
twenty	O
potentially	O
targetable	O
transcripts	O
within	O
pediatric	O
ACP	O
[	O
4	O
].	O

The	O
primary	O
clinical	O
question	O
underlying	O
this	O
research	O
is	O
to	O
determine	O
whether	B
initial	O
treatment	O
strategies	O
against	O
ACP	O
should	O
be	O
differentiated	O
based	O
on	O
age	O
at	O
diagnosis	O
.	O

Accordingly	O
,	O
we	O
validated	O
these	O
targets	O
in	O
the	O
current	O
dataset	O
compared	O
to	O
normal	O
pituitary	O
(	O
Figure	O
S1	O
)	O
and	O
created	O
a	O
subset	O
of	O
the	O
transcriptome	O
data	O
focusing	O
on	O
these	O
twenty	O
targets	O
to	O
assess	O
differential	O
expression	O
status	O
(	O
Fig	O
.<	O
U	O
+	O
00A0	O
>	O
2a	O
and	O
b	O
).	O

Of	O
the	O
previously	O
identified	O
potential	O
targets	O
,	O
three	O
genes	O
were	O
significant	O
(	O
IHW	O
p	O
-	O
value	O
<<	O
U	O
+	O
2009	O
>	O
0	O
.	O
1	O
):	O
SHH	O
,	O
MAPK14	O
,	O
and	O
AREG	O
.	O

Next	O
,	O
this	O
data	O
subset	O
was	O
subjected	O
to	O
the	O
same	O
divisive	O
,	O
agglomerative	O
,	O
and	O
probabilistic	O
clustering	O
protocols	O
(	O
Fig	O
.	O

2c	O
-	O
e	O
)	O
as	O
the	O
total	O
dataset	O
above	O
.	O

There	O
was	O
slight	O
improvement	O
in	O
data	O
organization	O
(	O
i	O
.	O
e	O
.,	O
an	O
increase	O
in	O
clustering	O
coefficients	O
;	O
DC	O
<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
0	O
.	O
78	O
,	O
and	O
AC	O
<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
0	O
.	O
77	O
,	O
relative	O
to	O
0	O
.	O
66	O
and	O
0	O
.	O
59	O
when	O
analyzing	O
the	O
full	O
transcriptome	O
).	O

Additionally	O
,	O
k	O
<	O
U	O
+	O
00A0	O
>=<	O
U	O
+	O
2009	O
>	O
2	O
remained	O
the	O
superior	O
cluster	O
count	O
but	O
higher	O
k	O
values	O
improved	O
relative	O
to	O
the	O
clustering	O
performance	O
of	O
the	O
full	O
transcriptome	O
(	O
Fig	O
.	O

2f	O
-	O
h	O
).	O

Although	O
four	O
genes	O
were	O
significantly	O
differentially	O
expressed	O
,	O
the	O
data	O
subset	O
remained	O
linearly	O
undifferentiable	O
based	O
on	O
age	O
.	O

In	O
other	O
words	O
,	O
these	O
results	O
indicate	O
that	O
there	O
is	O
no	O
direct	O
linear	O
relationship	O
between	O
transcriptional	O
profiles	O
and	O
age	O
group	O
at	O
diagnosis	O
.	O

Fig	O
.	O

2	O
Transcriptional	O
Profiling	O
of	O
Previously	O
Identified	O
Therapeutic	O
Targets	O
.	O

a	O
Previously	O
identified	O
therapeutic	O
targets	O
with	O
transcriptions	O
fold	O
-	O
change	O
metrics	O
for	O
adult	O
versus	O
pediatric	O
samples	O
.	O

A	O
positive	O
fold	O
-	O
change	O
indicates	O
enrichment	O
in	O
pediatric	O
patients	O
,	O
and	O
conversely	B
a	O
negative	O
value	O
indicates	O
enrichment	O
in	O
adult	O
patients	O
.	O

b	O
Volcano	O
plot	O
for	O
all	O
transcripts	O
with	O
previously	O
identified	O
targets	O
indicated	O
by	O
red	O
arrows	O
.	O

The	O
solid	O
black	O
horizontal	O
line	O
at	O
y	O
<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
1	O
indicates	O
the	O
threshold	O
for	O
p	O
-	O
value	O
significance	O
(	O
p	O
<	O
U	O
+	O
00A0	O
><<	O
U	O
+	O
2009	O
>	O
0	O
.	O
1	O
;	O
y	O
<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
><	O
U	O
+	O
2212	O
>	O
log	O
(	O
0	O
.	O
1	O
)<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
1	O
).	O

c	O
-	O
e	O
Clustering	O
paradigms	O
utilized	O
in	O
dataset	O
exploration	O
.	O

c	O
Dendrogram	O
yielded	O
from	O
the	O
DIvisive	O
ANAlysis	O
(	O
DIANA	O
)	O
hierarchical	O
clustering	O
algorithm	O
with	O
respect	O
to	O
only	O
the	O
twenty	O
previously	O
identified	O
targets	O
.	O

d	O
Dendrogram	O
produced	O
by	O
the	O
AGlomerative	O
NESting	O
(	O
AGNES	O
)	O
hierarchical	O
clustering	O
algorithm	O
using	O
complete	O
linkage	O
with	O
respect	O
to	O
only	O
the	O
twenty	O
previously	O
identified	O
targets	O
.	O

e	O
Clustering	O
partitions	O
and	O
group	O
ellipsoids	O
generated	O
by	O
the	O
fuzzy	O
analysis	O
(	O
FANNY	O
)	O
probabilistic	O
k	O
-	O
centroid	O
technique	O
with	O
respect	O
to	O
only	O
the	O
twenty	O
previously	O
identified	O
targets	O
.	O

f	O
-	O
h	O
Silhouette	O
plots	O
depicting	O
mean	O
silhouette	O
width	O
across	O
a	O
range	O
of	O
numbers	O
of	O
clusters	O
.	O

f	O
Silhouette	O
plot	O
generated	O
from	O
the	O
DIANA	O
clustering	O
presented	O
in	O
2c	O
.	O

g	O
Silhouette	O
plot	O
produced	O
by	O
the	O
AGNES	O
algorithm	O
output	O
presented	O
in	O
2d	O
.	O

h	O
Silhouette	O
plot	O
yielded	O
by	O
the	O
FANNY	O
algorithm	O
results	O
visualized	O
in	O
2e	O
.	O

Information	O
theory	O
and	O
machine	O
learning	O
techniques	O
identify	O
a	O
cohort	O
of	O
transcripts	O
relevant	O
to	O
differentiating	O
adult	O
and	O
pediatric	O
patients	O
In	O
the	O
present	O
context	O
,	O
Kullback	O
-	O
Leibler	O
divergence	O
(	O
DKL	O
)	O
represents	O
the	O
difference	O
between	O
transcript	O
expression	O
profiles	O
of	O
the	O
two	O
age	O
groups	O
(	O
Fig	O
.<	O
U	O
+	O
00A0	O
>	O
3a	O
).	O

DKL	O
is	O
asymmetric	O
,	O
so	O
we	O
visualize	O
both	O
directions	O
of	O
the	O
relationship	O
(	O
i	O
.	O
e	O
.,	O
Pediatrics	O
to	O
Adults	O
,	O
and	O
Adults	O
to	O
Pediatrics	O
;	O
Fig	O
.	O

3b	O
).	O

These	O
results	O
demonstrate	O
that	O
qualitatively	O
the	O
global	O
transcriptomes	O
of	O
both	O
age	O
groups	O
are	O
informationally	O
similar	O
.	O

Of	O
the	O
four	O
differentially	O
expressed	O
therapeutic	O
targets	O
,	O
SHH	O
and	O
AREG	O
demonstrate	O
the	O
greatest	O
informational	O
difference	O
(	O
DKL	O
<	O
U	O
+	O
2009	O
><	O
U	O
+	O
2248	O
><	O
U	O
+	O
2009	O
>	O
3	O
)	O
although	O
still	O
less	O
than	O
50	O
%	O
of	O
maximum	O
(	O
DKL	O
<	O
U	O
+	O
2009	O
><	O
U	O
+	O
2248	O
><	O
U	O
+	O
2009	O
>	O
6	O
)	O
informational	O
differences	O
(	O
i	O
.	O
e	O
.,	O
they	O
are	O
not	O
among	O
the	O
top	O
contributors	O
for	O
informational	O
difference	O
between	O
age	O
groups	O
).	O

Fig	O
.	O

3	O
Information	O
Theory	O
-	O
Based	O
Analysis	O
Suggests	O
Majority	O
of	O
Genes	O
Have	O
Minimal	O
Linear	O
and	O
Non	O
-	O
linear	O
Relationships	O
with	O
Age	O
Groups	O
.	O

a	O
Kullback	O
-	O
Leibler	O
(	O
KL	O
)	O
divergence	O
representation	O
of	O
SHH	O
(	O
top	O
)	O
and	O
IL6R	O
(	O
bottom	O
)	O
distributions	O
for	O
adult	O
and	O
pediatric	O
samples	O
.	O

b	O
KL	O
-	O
divergence	O
versus	O
Log	O
Fold	O
Change	O
plot	O
,	O
with	O
previously	O
identified	O
therapeutic	O
targets	O
overlaid	O
and	O
all	O
points	O
colored	O
by	O
IHW	O
-	O
adjusted	O
p	O
-	O
value	O
,	O
demonstrating	O
relationship	O
between	O
calculated	O
LFC	O
and	O
informational	O
differences	O
.	O

Higher	O
KL	O
-	O
Divergence	O
values	O
indicate	O
that	O
a	O
gene	O
has	O
informational	O
difference	O
between	O
age	O
groups	O
.	O

As	O
KL	O
-	O
Divergence	O
is	O
an	O
asymmetric	O
method	O
,	O
the	O
scenario	O
of	O
having	O
a	O
pediatric	O
prior	O
(	O
left	O
)	O
and	O
an	O
adult	O
prior	O
(	O
right	O
)	O
are	O
both	O
shown	O
.	O

c	O
Pearson	O
Correlation	O
Coefficient	O
(	O
PCC	O
)	O
vs	O
Maximal	O
Information	O
Criterion	O
(	O
MIC	O
)	O
plot	O
with	O
previously	O
identified	O
targets	O
overlaid	O
.	O

MIC	O
scores	O
the	O
strength	O
of	O
a	O
relationship	O
from	O
0	O
(	O
no	O
relationship	O
)	O
to	O
1	O
(	O
noise	O
-	O
free	O
relationship	O
)	O
for	O
genes	O
between	O
the	O
age	O
groups	O
.	O

Points	O
A	O
and	O
B	O
on	O
the	O
graph	O
represent	O
where	O
genes	O
should	O
fall	O
if	O
they	O
have	O
a	O
strong	O
direct	O
or	O
inverse	O
linear	O
relationship	O
with	O
age	O
groups	O
.	O

Values	O
that	O
have	O
low	O
PCC	O
and	O
high	O
MIC	O
scores	O
indicate	O
genes	O
with	O
non	O
-	O
linear	O
(	O
i	O
.	O
e	O
.	O

dynamic	O
;	O
one	O
-	O
vs	O
-	O
many	O
)	O
relationships	O
.	O

d	O
Summary	O
statistics	O
of	O
where	O
genes	O
lie	O
on	O
the	O
PCC	O
vs	O
MIC	O
plot	O
along	O
with	O
their	O
respective	O
differential	O
expression	O
values	O
as	O
visualized	O
in	O
(	O
b	O
).	O

We	O
analytically	O
assed	O
both	O
linear	O
and	O
non	O
-	O
linear	O
relationships	O
by	O
comparing	O
the	O
MIC	O
versus	O
Pearson	O
<	O
U	O
+	O
2019	O
>	O
s	O
R	O
(	O
Fig	O
.	O

3c	O
).	O

From	O
this	O
we	O
determined	O
that	O
of	O
the	O
41	O
,	O
914	O
transcripts	O
interrogated	O
only	O
0	O
.	O
03	O
%	O
(	O
N	O
<	O
U	O
+	O
00A0	O
>=<	O
U	O
+	O
2009	O
>	O
13	O
)	O
genes	O
maintain	O
expression	O
levels	O
that	O
differ	O
based	O
on	O
age	O
group	O
(	O
Fig	O
.	O

3d	O
).	O

The	O
encoded	O
genes	O
include	O
a	O
long	O
intergenic	O
non	O
-	O
protein	O
coding	O
gene	O
,	O
innate	O
immune	O
system	O
related	O
genes	O
,	O
a	O
chromosomal	O
open	O
reading	O
frame	O
,	O
and	O
a	O
keratin	O
metabolism	O
related	O
gene	O
.	O

When	O
cross	O
-	O
checked	O
with	O
canonical	O
differential	O
analysis	O
methods	O
,	O
four	O
genes	O
(	O
FBXL16	O
,	O
COG8	O
,	O
CHST2	O
,	O
and	O
TMCC2	O
)	O
were	O
statistically	O
significant	O
as	O
determined	O
by	O
p	O
-	O
value	O
.	O

However	B
,	O
Log	O
Fold	O
Change	O
(	O
LFC	O
)	O
magnitudes	O
were	O
less	O
than	O
1	O
for	O
all	O
but	O
FBXL16	O
(	O
LFC	O
<	O
U	O
+	O
2009	O
>=<	O
U	O
+	O
2009	O
>	O
1	O
.	O
38	O
).	O

Of	O
the	O
seven	O
genes	O
identified	O
,	O
none	O
are	O
currently	O
of	O
therapeutic	O
interest	O
.	O

Ontology	O
assessment	O
of	O
deep	O
learning	O
identified	O
age	O
group	O
-	O
differentiable	O
transcripts	O
Following	O
classification	O
using	O
the	O
HD	O
Spot	O
algorithm	O
,	O
the	O
50	O
(	O
0	O
.	O
20	O
%)	O
transcripts	O
with	O
the	O
highest	O
Shapley	O
values	O
(	O
Fig	O
.<	O
U	O
+	O
00A0	O
>	O
4a	O
)	O
and	O
the	O
20	O
previously	O
identified	O
potential	O
therapeutic	O
targets	O
were	O
examined	O
using	O
a	O
Metascape	O
analysis	O
(	O
Fig	O
.	O

4b	O
).	O

HD	O
Spot	O
identified	O
primarily	O
pseudogenes	O
,	O
novel	O
transcripts	O
,	O
and	O
non	O
-	O
coding	O
transcripts	O
as	O
most	O
differentiable	O
between	O
age	O
groups	O
.	O

Only	O
one	O
ontology	O
group	O
(	O
GO	O
:	O
0051222	O
)	O
is	O
enriched	O
in	O
HD	O
spot	O
analysis	O
and	O
it	O
is	O
also	O
enriched	O
(	O
though	O
more	O
significantly	O
)	O
with	O
respect	O
to	O
the	O
therapeutic	O
targets	O
.	O

The	O
lack	O
of	O
enrichment	O
returned	O
from	O
Metascape	O
analysis	O
reinforces	O
that	O
the	O
differential	O
genes	O
identified	O
are	O
not	O
well	O
studied	O
and	O
are	O
currently	O
not	O
of	O
therapeutic	O
interest	O
.	O

Importantly	O
,	O
HD	O
Spot	O
achieved	O
a	O
mean	O
5	O
-	O
fold	O
cross	O
-	O
validation	O
area	O
under	O
precision	O
-	O
recall	O
curve	O
value	O
of	O
0	O
.	O
97	O
,	O
indicating	O
that	O
the	O
derived	O
classifier	O
was	O
well	O
optimized	O
.	O

In	O
total	O
,	O
these	O
findings	O
indicate	O
that	O
while	B
there	O
may	O
be	O
underlying	O
transcriptional	O
difference	B
for	O
ACP	O
pathogensis	O
relative	O
to	O
pediatric	O
and	O
adult	O
patients	O
,	O
current	O
therapeutic	O
targets	O
do	O
not	O
maintain	O
age	O
-	O
dependent	O
linear	O
or	O
non	O
-	O
linear	O
expression	O
signatures	O
.	O

Fig	O
.	O

4	O
Deep	O
Learning	O
Approach	O
HD	O
Spot	O
Identifies	O
Genes	O
Related	O
to	O
Adult	O
and	O
Pediatric	O
Cohort	O
Differences	O
From	O
Raw	O
Feature	O
Counts	O
.	O

a	O
Summary	O
plot	O
of	O
the	O
top	O
50	O
genes	O
identified	O
by	O
HD	O
Spot	O
as	O
being	O
the	O
most	O
important	O
in	O
separating	O
adult	O
and	O
pediatric	O
ACP	O
transcriptomes	O
.	O

b	O
Heatmap	O
of	O
GO	O
terms	O
found	O
to	O
be	O
enriched	O
in	O
Metascape	O
analysis	O
comparing	O
HD	O
Spot	O
-	O
identified	O
and	O
the	O
20	O
previously	O
identified	O
therapeutic	O
targets	O
.	O

Heatmap	O
color	O
represents	O
ontology	O
term	O
enrichment	O
.	O

Discussion	O
Using	O
a	O
thorough	O
comparative	O
bioinformatic	O
analysis	O
following	O
bulk	O
tissue	O
RNA	O
sequencing	O
of	O
pediatric	O
and	O
adult	O
ACP	O
tissue	O
,	O
we	O
identified	O
no	O
gene	O
expression	O
differences	O
that	O
have	O
implications	O
regarding	O
potential	O
therapies	O
.	O

This	O
implies	O
that	O
potential	O
therapies	O
identified	O
or	O
initially	O
tested	O
in	O
either	O
the	O
adult	O
or	O
pediatric	O
population	O
will	O
have	O
relevance	O
in	O
the	O
other	B
age	O
group	O
.	O

To	O
our	O
knowledge	O
this	O
work	O
consists	O
of	O
the	O
largest	O
analysed	O
cohort	O
of	O
ACP	O
transcriptome	O
data	O
to	O
date	O
.	O
Canonical	O
differential	O
expression	O
techniques	O
demonstrated	O
no	O
clear	O
differences	O
between	O
age	O
groups	O
.	O

At	O
the	O
global	O
level	O
,	O
only	O
12	O
and	O
13	O
%	O
of	O
transcripts	O
yielded	O
a	O
Log	O
Fold	O
Change	O
(	O
LFC	O
)	O
with	O
an	O
IHW	O
-	O
adjusted	O
p	O
-	O
value	O
<<	O
U	O
+	O
2009	O
>	O
0	O
.	O
1	O
.	O

Using	O
divisive	O
,	O
agglomerative	O
,	O
and	O
probabilistic	O
hierarchical	O
clustering	O
approaches	O
,	O
we	O
observed	O
that	O
while	O
clustering	O
was	O
at	O
a	O
relative	O
optimum	O
with	O
k	O
<	O
U	O
+	O
00A0	O
>=<	O
U	O
+	O
2009	O
>	O
2	O
clusters	O
,	O
cluster	O
memberships	O
were	O
arbitrary	O
(	O
mean	O
silhouette	O
widths	O
<<	O
U	O
+	O
2009	O
>	O
0	O
.	O
35	O
)	O
and	O
contained	O
a	O
mixture	O
of	O
age	O
groups	O
in	O
each	O
branch	O
.	O

In	O
the	O
context	O
of	O
the	O
twenty	O
previously	O
identified	O
potential	O
therapeutic	O
targets	O
,	O
we	O
found	O
that	O
only	O
SHH	O
,	O
AREG	O
,	O
and	O
MAPK14	O
were	O
differentially	O
expressed	O
with	O
adjusted	O
p	O
-	O
value	O
<<	O
U	O
+	O
2009	O
>	O
0	O
.	O
1	O
.	O

Analysis	O
of	O
these	O
20	O
transcripts	O
demonstrated	O
the	O
same	O
clustering	O
performance	O
results	O
that	O
were	O
observed	O
with	O
analysis	O
of	O
the	O
entire	O
transcriptome	O
.	O

Specifically	O
,	O
adult	O
and	O
pediatric	O
patients	O
did	O
not	O
cluster	O
uniquely	O
and	O
inter	O
-	O
cluster	O
members	O
could	O
arbitrarily	O
be	O
replaced	O
by	O
intra	O
-	O
cluster	O
members	O
.	O
The	O
findings	O
from	O
the	O
canonical	O
techniques	O
were	O
confirmed	O
through	O
further	O
analysis	O
using	O
information	O
theory	O
principles	O
.	O

This	O
demonstrated	O
that	O
99	O
.	O
97	O
%	O
of	O
the	O
transcriptome	O
has	O
no	O
expression	O
level	O
relationship	O
with	O
the	O
age	O
group	O
of	O
the	O
patient	O
.	O

The	O
remaining	O
0	O
.	O
03	O
%	O
was	O
composed	O
of	O
a	O
mixed	O
collection	O
of	O
transcripts	O
that	O
have	O
not	O
been	O
implicated	O
in	O
tumor	O
pathogenesis	O
or	O
therapy	O
,	O
and	O
LFCs	O
were	O
modest	O
.	O
Next	O
,	O
we	O
sought	O
to	O
qualitatively	O
examine	O
non	O
-	O
linear	O
transcriptional	O
relationships	O
to	O
age	O
group	O
by	O
utilizing	O
KL	O
-	O
divergence	O
.	O

This	O
again	O
demonstrated	O
that	O
the	O
global	O
transcriptome	O
profile	O
for	O
pediatric	O
ACP	O
differs	O
very	O
little	O
from	O
that	O
of	O
adult	O
ACP	O
.	O

Quantitative	O
assessment	O
of	O
linear	O
and	O
non	O
-	O
linear	O
relationships	O
using	O
MIC	O
vs	O
.	O
Pearson	O
<	O
U	O
+	O
2019	O
>	O
s	O
R	O
plots	O
revealed	O
that	O
over	O
99	O
%	O
of	O
transcripts	O
do	O
not	O
possess	O
strong	O
relationships	O
of	O
any	O
type	O
to	O
age	O
group	O
.	O

Importantly	O
,	O
the	O
required	O
synthetic	O
expansion	O
of	O
the	O
dataset	O
(	O
see	O
Methods	O
)	O
in	O
order	O
to	O
calculate	O
DKL	O
and	O
MIC	O
would	O
be	O
expected	O
to	O
artificially	O
magnify	O
any	O
data	O
relationships	O
.	O

Therefore	O
,	O
the	O
lack	O
of	O
any	O
clear	O
relationship	O
between	O
transcript	O
expression	O
and	O
age	O
group	O
in	O
this	O
context	O
further	O
supports	O
the	O
assertion	O
that	O
the	O
adult	O
and	O
pediatric	O
transcriptomes	O
lack	O
therapeutically	O
relevant	O
differeces	O
.	O
The	O
threshold	O
selected	O
to	O
distinguish	O
adult	O
from	O
pediatric	O
ACP	O
(	O
age	O
18	O
<	O
U	O
+	O
2009	O
>	O
years	O
)	O
may	O
be	O
considered	O
arbitrary	O
.	O

However	B
,	O
the	O
bimodal	O
age	O
distribution	O
of	O
ACP	O
incidence	O
includes	O
a	O
nadir	O
between	O
age	O
20	O
and	O
age	O
39	O
.	O

This	O
implies	O
that	O
there	O
may	O
be	O
a	O
distinction	O
,	O
on	O
some	O
level	O
,	O
between	O
the	O
tumors	O
that	O
present	O
before	O
and	O
after	O
this	O
window	O
.	O

The	O
age	O
threshold	O
of	O
18	O
<	O
U	O
+	O
2009	O
>	O
years	O
has	O
further	O
clinical	O
significance	O
because	O
it	O
relates	O
to	O
the	O
clinical	O
environment	O
(	O
pediatric	O
vs	O
.	O
adult	O
)	O
in	O
which	O
a	O
patient	O
may	O
receive	O
care	O
.	O

Furthermore	O
,	O
by	O
leveraging	O
the	O
deep	O
learning	O
technique	O
HD	O
Spot	O
,	O
we	O
identified	O
genes	O
,	O
in	O
a	O
manner	O
free	O
of	O
human	O
-	O
interpreter	O
bias	O
,	O
that	O
have	O
age	O
group	O
dependent	O
expression	O
profiles	O
.	O

HD	O
Spot	O
accurately	O
discriminated	O
between	O
pediatric	O
and	O
adult	O
transcriptomes	O
.	O

The	O
top	O
50	O
genes	O
contributing	O
to	O
this	O
classification	O
were	O
primarily	O
comprised	O
of	O
genomic	O
features	O
that	O
are	O
currently	O
poorly	O
understood	O
(	O
e	O
.	O
g	O
.,	O
pseudogenes	O
,	O
novel	O
transcripts	O
,	O
etc	O
.).	O

Through	O
utilizing	O
classical	O
genomic	O
analysis	O
protocols	O
,	O
information	O
theoretic	O
models	O
,	O
and	O
deep	O
learning	O
this	O
work	O
rigorously	O
interrogated	O
linear	O
and	O
non	O
-	O
linear	O
relationships	O
to	O
demonstrate	O
that	O
,	O
at	O
the	O
transcript	O
level	O
,	O
there	O
is	O
no	O
evidence	O
to	O
differentiate	O
therapy	O
between	O
adult	O
and	O
pediatric	O
ACP	O
patients	O
strictly	O
based	O
on	O
age	O
at	O
diagnosis	O
.	O

Limitations	O
Despite	O
the	O
rigorous	O
characterization	O
of	O
the	O
transcriptional	O
relationship	O
between	O
pediatric	O
and	O
adult	O
ACP	O
tumor	O
tissue	O
,	O
our	O
findings	O
are	O
limited	O
by	O
the	O
fact	O
that	O
only	O
RNA	O
expression	O
profiles	O
were	O
considered	O
.	O

This	O
provides	O
a	O
specific	O
window	O
into	O
the	O
genomic	O
landscape	O
.	O

It	O
does	O
not	O
provide	O
thorough	O
insight	O
into	O
potential	O
differences	B
in	O
the	O
epigenetic	O
environment	O
or	O
extracellular	O
milieu	O
between	O
pediatric	O
and	O
adult	O
ACP	O
.	O

Furthermore	O
,	O
the	O
transcriptome	O
data	O
analyzed	O
was	O
generated	O
through	O
bulk	O
RNA	O
sequencing	O
.	O

Given	O
heterogeneous	O
nature	O
of	O
ACP	O
tissue	O
,	O
bulk	O
sequencing	O
is	O
likely	O
to	O
lose	O
some	O
information	O
,	O
which	O
may	O
be	O
explored	O
in	O
more	O
detail	O
with	O
techniques	O
such	O
as	O
single	O
cell	O
RNAseq	O
,	O
RNA	O
mutation	O
analysis	O
or	O
protein	O
-	O
level	O
quantification	O
.	O

Lastly	O
,	O
there	O
is	O
also	O
still	O
potential	O
that	O
an	O
even	O
larger	O
dataset	O
contrasting	B
these	O
age	O
groups	O
(	O
which	O
to	O
our	O
knowledge	O
does	O
not	O
exist	O
)	O
may	O
still	O
reveal	O
more	O
therapeutically	O
important	O
differences	O
.	O

Such	O
studies	O
may	O
identify	O
biological	O
distinctions	O
that	O
could	O
guide	O
therapeutic	O
intervention	O
,	O
even	O
if	B
this	O
is	O
at	O
the	O
level	O
of	O
second	O
or	O
third	O
line	O
therapy	O
.	O

Conclusions	O
Analysis	O
using	O
multiple	O
bioinformatic	O
techniques	O
,	O
including	O
the	O
Deep	O
Learning	O
method	O
,	O
HD	O
Spot	O
,	O
indicates	O
that	O
there	O
is	O
no	O
therapeutically	O
relevant	O
distinction	O
between	O
ACP	O
tissuein	O
adult	O
and	O
pediatric	O
patient	O
.	O

This	O
implies	O
that	O
the	O
identification	O
of	O
biologically	O
-	O
guided	O
therapeutic	O
targets	O
,	O
and	O
the	O
potential	O
clinical	O
translation	O
of	O
such	O
targets	O
in	O
either	B
group	O
of	O
patients	O
may	O
also	O
be	O
relevant	O
in	O
the	O
other	O
.	O

As	O
such	O
,	O
recent	O
and	O
future	O
findings	O
regarding	O
ACP	O
may	O
be	O
applied	O
for	O
the	O
benefit	O
of	O
a	O
larger	O
group	O
of	O
patients	O
.	O

Future	O
work	O
including	O
more	O
in	O
depth	O
study	O
of	O
RNA	O
features	O
,	O
protein	O
expression	O
and	O
extracellular	O
characteristics	O
of	O
these	O
tumors	O
will	O
be	O
necessary	O
.	O

